Yttrium-90 Radioembolization of Metastatic Adrenocortical Carcinoma to the Liver following Systemic Chemotherapy and Surgical Resection of the Primary Lesion.

Nicholas Pigg; Daniel Aboubechara; Roberto Fourzali; Brian Baigorri

doi:10.1159/000504779

Yttrium-90 Radioembolization of Metastatic Adrenocortical Carcinoma to the Liver following Systemic Chemotherapy and Surgical Resection of the Primary Lesion.

Nicholas Pigg
, Daniel Aboubechara
, Roberto Fourzali
, Brian Baigorri

HCA Florida Aventura Hospital

Department of Radiology, Aventura Hospital and Medical Center, Aventura, Florida, USA.

Research output: Contribution to journal › Article › peer-review

Original language	American English
Journal	Case Reports in Oncology
Volume	13
Issue number	1
DOIs	https://doi.org/10.1159/000504779
State	Published - Feb 17 2020

Disciplines

Medicine and Health Sciences
Radiology

Access to Document

10.1159/000504779License: Unspecified

Cite this

@article{37c6e1d1d49d49d08263a5238593bb9a,

title = "Yttrium-90 Radioembolization of Metastatic Adrenocortical Carcinoma to the Liver following Systemic Chemotherapy and Surgical Resection of the Primary Lesion.",

author = "Nicholas Pigg and Daniel Aboubechara and Roberto Fourzali and Brian Baigorri",

note = "Use of yttrium-90 (Y-90) is used for primary liver tumors and a handful of liver metastatic lesions. Y-90 treatment for metastatic adrenocortical carcinoma (ACC) to the liver is currently off-label, with one previously documented case report. In this case report, we present a 52-year-old woman with ACC and extensive liver metastatic disease.",

year = "2020",

month = feb,

day = "17",

doi = "10.1159/000504779",

language = "American English",

volume = "13",

journal = "Case Reports in Oncology",

publisher = "Karger",

number = "1",

}

TY - JOUR

T1 - Yttrium-90 Radioembolization of Metastatic Adrenocortical Carcinoma to the Liver following Systemic Chemotherapy and Surgical Resection of the Primary Lesion.

AU - Pigg, Nicholas

AU - Aboubechara, Daniel

AU - Fourzali, Roberto

AU - Baigorri, Brian

N1 - Use of yttrium-90 (Y-90) is used for primary liver tumors and a handful of liver metastatic lesions. Y-90 treatment for metastatic adrenocortical carcinoma (ACC) to the liver is currently off-label, with one previously documented case report. In this case report, we present a 52-year-old woman with ACC and extensive liver metastatic disease.

PY - 2020/2/17

Y1 - 2020/2/17

UR - https://europepmc.org/article/MED/32231538

U2 - 10.1159/000504779

DO - 10.1159/000504779

M3 - Article

VL - 13

JO - Case Reports in Oncology

JF - Case Reports in Oncology

IS - 1

ER -

Yttrium-90 Radioembolization of Metastatic Adrenocortical Carcinoma to the Liver following Systemic Chemotherapy and Surgical Resection of the Primary Lesion.

Disciplines

Access to Document

Other files and links

Cite this